Indegene Limited — Important, 19-03-2025: Updates

The Board of Directors of Indegene Limited has approved a significant investment of up to €5.2 million in its wholly-owned subsidiary, Indegene Ireland Limited, aimed at supporting its capital expenditure needs for expansion. Indegene Ireland, which provides various services to the life sciences and healthcare sectors, reported a turnover of €596,780 for the fiscal year ending March 31, 2024. This strategic move reflects the company’s commitment to bolster its subsidiary’s growth by enhancing its operational capabilities. The investment is expected to be executed in multiple tranches by April 30, 2026. Additionally, the Board has re-appointed Mr. Madhwesh K as Secretarial Auditor for FY 2024-25 and recommended M/s Madhwesh Prathap and Associates for a five-year term, pending shareholder approval. This governance structure aims to ensure compliance and robust corporate management as Indegene continues to navigate its growth trajectory. Investors should watch closely as these developments could enhance operational efficiencies and market competitiveness.